Notes
see Reactions 1483 p3; 803097108
Reference
EMA. PRAC re-examines diacerein and recommends that it remain available with restrictions. Internet Document : [2 pages], 7 Mar 2014. Available from: URL: http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Diacerein/Recommendation_provided_by_Pharmacovigilance_Risk_Assessment_Committee/WC500162555.pdf
Rights and permissions
About this article
Cite this article
Diacerein to stay, but with restrictions. Reactions Weekly 1493, 2 (2014). https://doi.org/10.1007/s40278-014-9482-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-014-9482-z